1. Home
  2. PHIO vs NUAI Comparison

PHIO vs NUAI Comparison

Compare PHIO & NUAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHIO
  • NUAI
  • Stock Information
  • Founded
  • PHIO 2011
  • NUAI N/A
  • Country
  • PHIO United States
  • NUAI United States
  • Employees
  • PHIO N/A
  • NUAI N/A
  • Industry
  • PHIO Biotechnology: Pharmaceutical Preparations
  • NUAI Oil & Gas Production
  • Sector
  • PHIO Health Care
  • NUAI Energy
  • Exchange
  • PHIO Nasdaq
  • NUAI Nasdaq
  • Market Cap
  • PHIO 12.1M
  • NUAI 10.4M
  • IPO Year
  • PHIO N/A
  • NUAI N/A
  • Fundamental
  • Price
  • PHIO $2.16
  • NUAI $5.64
  • Analyst Decision
  • PHIO Strong Buy
  • NUAI
  • Analyst Count
  • PHIO 3
  • NUAI 0
  • Target Price
  • PHIO $10.67
  • NUAI N/A
  • AVG Volume (30 Days)
  • PHIO 70.7K
  • NUAI 31.8M
  • Earning Date
  • PHIO 11-13-2025
  • NUAI 11-14-2025
  • Dividend Yield
  • PHIO N/A
  • NUAI N/A
  • EPS Growth
  • PHIO N/A
  • NUAI N/A
  • EPS
  • PHIO N/A
  • NUAI N/A
  • Revenue
  • PHIO N/A
  • NUAI $718,761.00
  • Revenue This Year
  • PHIO N/A
  • NUAI N/A
  • Revenue Next Year
  • PHIO N/A
  • NUAI N/A
  • P/E Ratio
  • PHIO N/A
  • NUAI N/A
  • Revenue Growth
  • PHIO N/A
  • NUAI 14.80
  • 52 Week Low
  • PHIO $0.97
  • NUAI $0.32
  • 52 Week High
  • PHIO $9.79
  • NUAI $12.29
  • Technical
  • Relative Strength Index (RSI)
  • PHIO 47.27
  • NUAI 66.96
  • Support Level
  • PHIO $2.08
  • NUAI $3.63
  • Resistance Level
  • PHIO $2.17
  • NUAI $6.71
  • Average True Range (ATR)
  • PHIO 0.10
  • NUAI 1.17
  • MACD
  • PHIO -0.01
  • NUAI 0.23
  • Stochastic Oscillator
  • PHIO 25.64
  • NUAI 79.26

About PHIO Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

About NUAI New Era Energy & Digital Inc. Common Stock

New Era Energy & Digital Inc is engaged into a fully integrated energy supplier delivering next-gen digital infrastructure and power assets. The company provides turnkey solutions to speed up data center deployment and reduce costs. The company focuses on future-proofing infrastructure for hyperscale, enterprise, and edge operators. The company provide integrated energy and digital solutions to support accelerating AI infrastructure deployment and optimize data center investments.

Share on Social Networks: